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Argonaute proteins lie at the heart of the RNA-
induced silencing complex (RISC), wherein they use
small RNA guides to recognize targets. Initial insight
into the architecture of Argonautes came from
studies of prokaryotic proteins, revealing a cres-
cent-shaped base made up of the amino-terminal,
PAZ, middle, and PIWI domains. The recently re-
ported crystal structure of human Argonaute-2
(hAgo2), the ‘‘slicer’’ in RNA interference, in complex
with a mixed population of RNAs derived from insect
cells provides insight into the architecture of a eu-
karyotic Argonaute protein with defined biochemical
and biological functions. Here, we report the struc-
ture of human Ago2 bound to a physiologically rele-
vant microRNA, microRNA-20a, at 2.2 A˚ resolution.
The miRNA is anchored at both ends by the Mid
and PAZ domains and makes several kinks and turns
along the binding groove. Interestingly, miRNA
binding confers remarkable stability on hAgo2, lock-
ing this otherwise flexible enzyme into a stable
conformation.
INTRODUCTION
A universal feature of RNAi-related pathways is their reliance on
Argonaute family proteins, which bind small RNAs and use these
as guides to select their silencing targets (Joshua-Tor and Han-
non, 2011). Early work suggested association between Argo-
naute and small RNAs within RISC (Hammond et al., 2001).
This was confirmed by studies of the isolated PAZ (P-element
induced wimpy testes [PIWI], Argonaute and Zwille) domain,
whose structure revealed an oligonucleotide-binding fold that
engaged the 30 ends of small RNA guides (Lingel et al., 2003,
2004; Ma et al., 2004; Song et al., 2003; Yan et al., 2003). Their
50 ends occupy a pocket within the Argonaute Mid domain,
which may confer 50 end nucleotide preferences upon some
Ago family members (Boland et al., 2010; Frank et al., 2010;
Ma et al., 2005; Mi et al., 2008; Parker et al., 2005).100 Cell 150, 100–110, July 6, 2012 ª2012 Elsevier Inc.A critical insight came with the realization that Argonaute
proteins were directly responsible for small RNA-directed
silencing, embodying the endonucleolytic ‘‘slicer’’ activity of
RISC (Song et al., 2004). The PIWI domain resembled an RNase
H enzyme, a relationship that could not be inferred from primary
sequence but which was apparent from similarity of their tertiary
structures. This type of enzyme was consistent with the known
biochemistry of the slicing reaction, which produced 50 phos-
phate and 30 hydroxyl termini (Martinez and Tuschl, 2004;
Schwarz et al., 2004). It also pointed to key aspartate residues
within a presumed Argonaute active site (Liu et al., 2004; Song
et al., 2004). Reconstitution experiments with purified compo-
nents verified that the minimal complex needed for target
cleavage is hAgo2, a guide strand, and Mg2+ (MacRae et al.,
2008; Rivas et al., 2005). The Argonaute active site is proximal
to a large positively charged groove, which could accommodate
the small RNA guide and its base-paired target, placing the scis-
sile bond directly adjacent to the active site (Song et al., 2004).
The two other domains in the structure, the N-terminal (N)
domain and the Mid domain are apparent in all Argonaute struc-
tures solved to date.
A series of structures of the bacterial Thermus thermophilus
Argonaute (TtAgo) bound to various combinations of DNA guide
strands and RNA and DNA target strands (Wang et al., 2008b;
Wang et al., 2009; Wang et al., 2008c) provided a great deal of
insight into the conformational changes in both the protein and
the RNA that accompany the action of the slicer enzyme. Two
structures with substrates of different lengths (Wang et al.,
2009) illustrate the range of motions that the PAZ domain can
undergo in the catalytic cycle.Moreover, they reveal the disasso-
ciation of the 30 end of the guide from the PAZ domain upon
target binding as first proposed by Zamore and colleagues
based upon their biochemical characterization of RISC (Schwarz
et al., 2004).
Our understanding of the architecture of full-length Argonaute
proteins has until recently been based on structures of prokary-
otic Argonautes of unknown biochemical and biological
function. Insight into the architecture of eukaryotic Argonautes
initially came from individual protein domains, including early
studies of human and Drosophila PAZ domains (Lingel et al.,
2003, 2004; Ma et al., 2004; Song et al., 2003; Yan et al., 2003)
and structures of Mid domains from the Neurospora crassa
Argonaute QDE-2 (Boland et al., 2010) and from hAgo2
(Frank et al., 2010). These revealed a structural basis for
50-nucleotide recognition of the guide strand and for the
sequence bias toward uridine monophosphate that is observed
in RNAs bound to eukaryotic Argonautes. Subsequently, the
structure of theMid-PIWI lobe of QDE-2was determined (Boland
et al., 2011), hinting to a conserved mode of nucleic acid binding
between prokaryotic and eukaryotic Argonautes. Recently,
Schirle and Macrae (2012) reported the crystal structure of full-
length human Argonaute-2 bound to a mixed population of
RNA guides. This study revealed the architecture of hAgo2,
showing that the overall domain organization and mode of small
RNA binding is similar to that of prokaryotic Argonautes. These
findings also begin to establish a structural basis for aspects of
Argonaute biology unique to eukaryotes, such as binding of
GW family proteins.
Having successfully developed an approach to purify hAgo2
devoid of a nucleic acid partner, wewere interested in character-
izing the structure of Argonaute-2 bound to a physiologically
relevant miRNA. Here, we report the structure of the full-length
hAgo2 in complex with miR-20a, to 2.2 A˚ resolution. We find
that the domain organization is strikingly similar to that seen
in prokaryotic proteins, as also noted by Shirle and Macrae
(2012). However, hAgo2 presents a more open conformation,
largely due to the PAZ domain sitting further from the remainder
of the protein. The miRNA is bound at both ends—the 50 end to
the Mid domain with some contributions from the PIWI domain,
and the 30 end to the PAZ domain. The seed sequence is in
a narrow portion of the RNA binding groove, and several kinks
caused by Argonaute residues protruding into the groove control
the trajectory of the RNA along the protein. As the miRNA
threads along the protein, it interacts with every domain of
hAgo2 including its linkers. We find that the RNA confers
remarkable stability on the enzymemost likely as a consequence
of these interactions being spread along the entire protein.
Together with the recent report by Schirle and Macrae (2012),
our findings provide key insights into a mammalian Argonaute
protein of essential biological functions.
RESULTS
Recombinant hAgo2 Copurifies with Small RNAs
For crystallographic studies, we isolated hAgo2 from baculovi-
rus-infected SF9 cells. Through the course of our purification,
hAgo2 showed an unusually low A280/A260 ratio, indicating the
potential presence of copurifying nucleic acids. We extracted
RNA from hAgo2 fractions at different stages of our purification
process and analyzed these by denaturing PAGE. We noted
a strong band of 20 nucleotides (Figure S1A available online),
suggesting that hAgo2 might have become loaded with endoge-
nous small RNA species in insect cells.
To investigate the nature of the bound RNAs, we used stan-
dard small RNA cloning and followed this with deep sequencing
on the Illumina platform. hAgo2 bound small RNAs show a non-
Gaussian distribution with a strong enrichment for RNAs of 20
nucleotides (Figure S1B). SF9 cells are derived from the fall
armyworm, Spodoptera frugiperda. Because we lack an assem-
bled, annotated genome for this organism, we sequenced smallRNA populations from SF9 for comparison to those bound to re-
combinant hAgo2.
SF9 is thought to be derived from Spodoptera female germ
cells. In accord with this notion, we see two general size classes
of small RNAs in libraries designed to capture species of 19-29
nucleotides (Figure S1C). One peak, comprising 19–23 nucle-
otides is likely to represent endogenous siRNAs andmicroRNAs.
This is supported by comparisons to Drosophila, which reveal
multiple shared miRNAs that appear mainly in SF9 cells as 23
nucleotide species. A second peak encompassing 25-28
nucleotides likely represents armyworm piRNAs, though
we failed to find substantial enrichment among these for small
RNAs that could be unambiguously mapped to known
Drosophila transposons.
To determine whether recombinant hAgo2 was being loaded
with bona fide SF9 small RNAs, we compared hAgo2-bound
species to the various size categories of SF9 small RNAs.
Because we lack a genome against which to filter for only
mapping reads, we considered those RNAs represented by
more than 10 reads to reduce spurious background in the
sequencing. In hAgo2 these comprised 49,000 different
sequences. Of the SF9 small RNAs in the 20-21 nucleotide size
range, sequences matching small RNAs in hAgo2 accounted
for 80% of all reads. In the 22-23 nt size range, 86% of all
sequence reads could be found among hAgo2 bound species.
In contrast, for presumptive piRNAs, only 17% of reads could
be accounted for by hAgo2 bound species, and this might be
an overestimate because in other insects, piRNAs and endoge-
nous siRNAs often overlap because of their enrichment for trans-
poson content.
We conclude that hAgo2 samples endogenous SF9 small
RNA populations. Given the tight size distribution of hAgo2-
bound RNAs, it must either select strongly for variants of SF9
small RNAs that are 20 nt in length or initially acquire longer
small RNAs that are subsequently trimmed to a size optimal for
hAgo2 occupancy. Support for the former hypothesis can be
derived from experiments in which a 21 nt human miRNA was
coexpressed in SF9 cells with hAgo2. In this case, the size distri-
bution profile shifted toward the 21 nt range when hAgo2
became loaded with this abundant, overexpressed RNA (data
not shown).
hAgo2 is normally found in association with a small RNA
population that is enriched for U at the 50 end. In part, this reflects
a bias in human miRNAs, but it is also driven by a higher affinity
of the 50-end binding pocket in the Mid domain for U and A
residues (Boland et al., 2010). When we analyzed the small
RNAs selected by hAgo2 from SF9 cells, we did note a 50 nucle-
otide bias with U and A being strongly preferred over C and G
(Figure S1D). This bias was slightly greater than that seen in
20 nt SF9 small RNAs (Figure S1E) and in total SF9 small RNA
populations (data not shown).
Because our goal was to analyze the structure of hAgo2 in
complex with a single, human microRNA, we attempted to
exchange bound endogenous species for synthetic RNAs.
Though this was unsuccessful, our experiments did indicate
the presence of a fraction of hAgo2 that was not loaded with
an endogenous RNA and that could accept an exogenously
added species.Cell 150, 100–110, July 6, 2012 ª2012 Elsevier Inc. 101
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Figure 1. Small RNAs Stabilize hAgo2
(A) Digestion of hAgo2, purified without bound, endogenous small RNAs
(Figure 1, lane ‘‘not bound to RNA’’) with thermolysin resulted in a digestion
pattern of typical multidomain proteins. Increasing concentrations of enzyme
(indicated by the wedge) released stable protein fragments corresponding to
known domains (indicated), as determined by N-terminal sequencing or mass
spectrometry. In contrast, treatment of hAgo2 purified along with endogenous
SF9 small RNAs was remarkably protease resistant (B).
(C) Addition of synthetic miR-20a (1–20) to the fraction shown in (A) conferred
stability to protease. See also Figures S1 and S2.hAgo2 Is Stabilized by Small RNA Binding
The complex of hAgo2 and endogenous small RNAs copurified
with the nonloaded hAgo2 protein through several chromato-
graphic steps. However, we were able to separate these species
by cation exchange chromatography (Figure S2A). We investi-
gated the domain structure of hAgo2 in the loaded and non-
loaded state by limited proteolytic digestion with thermolysin.
The hAgo2 thatwas not loadedwith a small RNAshowed adiges-
tion pattern typical of multidomain proteins. Moderate concen-
trations of protease released portions of hAgo2 that correspond
to structured domains. In this case, thermolysin liberated a
fragment corresponding to the N-terminal and PAZ domains
(N-PAZ), a fragment corresponding to theMid and PIWI domains
(Mid-PIWI), and a fragment comprising the PIWI domain alone
(PIWI; Figure 1A). In contrast, hAgo2 that was loadedwith a small
RNA resisted digestion by thermolysin at concentrations of
protease that reduced nearly all of the nonloaded protein to its
constituent domains (Figure 1B). Structural differences between
the two hAgo2 populations could be conferred by RNA binding102 Cell 150, 100–110, July 6, 2012 ª2012 Elsevier Inc.or could reflect another difference between these protein frac-
tions, for example a post-translational modification of hAgo2
that occurred in vivo following small RNA loading.
We previously found that we could add synthetic guide
sequences of various lengths to hAgo2 purified from bacteria
(Rivas et al., 2005). Similarly, we could efficiently incorporate
RNAs ranging from 12 to 21 nucleotides in length into the hAgo2
that was purified from insect cells without a native small RNA
(data not shown). hAgo2 loaded in this manner showed the
same unusual resistance to protease digestion as did hAgo2
purified along with SF9-derived guides, strongly indicating that
RNA binding is sufficient to lock the protein into a highly stable,
protease-resistant structure (Figure 1C). Given its tendency to
select 20 nucleotide guides in vivo, we elected to load hAgo2
witha20nucleotidesmallRNA invitro for crystallographic studies.
For this purpose, we synthesized a small RNA corresponding to
the first 20 nucleotides of human miR-20a (Figure S2B).
miR-20a is a component of the miR-17-92 cluster, which has
been ascribed a variety of context-dependent biological func-
tions. This cluster is important for heart and lung development
and for proper lymphoid differentiation (Kent and Mendell,
2006). It can also act as an oncogene or a tumor suppressor
depending upon the cell type in which it is expressed (Rizzo
et al., 2010). miR-20a itself is highly abundant in ES cells, where
it regulates the cell cycle and promotes proliferation (Wang
et al., 2008a).
Overall Structure of hAgo2 in the hAgo2-miR-20a
Complex
Weobtainedcrystalsof full-lengthhAgo2 incomplexwithmiR-20a
(1–20). These diffracted to 2.2 A˚ resolution. We solved the
structure of the complex by Single Anomalous Dispersion (SAD)
by using a selenomethionine-substituted protein and refined it
to 2.2 A˚ resolution with Rwork/Rfree of 20.6%/25.4%. For details
of the structure solution, data collection, and refinement statis-
tics, please refer to Experimental Procedures and to Table 1.
In its overall structure, hAgo2 in complex with miR-20a is very
similar to the complex obtained with a mixed population of RNA
(Schirle and Macrae, 2012). These structures are remarkably
similar to the archaeal and bacterial Argonautes, whose struc-
tures were previously determined (Figures 2 and S3). The Mid
and PIWI domains form an almost continuous lobe with the N
domain completing a crescent or cradle shape. Above this, the
PAZ domain wraps over the RNA binding groove. We previously
likened the structure of Argonaute to a duck. The crescent
formed by the Mid and PIWI domains forms the body, and the
PAZ domain serves as the head, with the 30 end of the RNA
guide being held in the bill. The N domain could be thought of
as a wing folding over the RNA guide and mRNA substrate.
Using this analogy, we found that the neck holding the PAZ
domain appears to be elongated in comparison to prokaryotic
Argonautes (Figure 3). This makes hAgo2 the most open
Argonaute structure to date with the PAZ domain lying further
away from the other domains and the ‘‘bill’’ pointing upwards.
hAgo2 is even more open than the thermophilus protein (TtAgo)
that was crystallized with both the guide and target strands
(Figure 3). In the crystal, there is a packing interaction between
the PAZ domain and a neighboring molecule in the form of a salt
Table 1. Data Collection and Refinement Statistics
Data collection Native SeMet
Cell dimensions
a, b, c (A˚) 63.4, 107.7, 68.7 63.3, 108.2, 68.6
a, b, g () 90.0, 106.7, 90.0 90.0, 107.2, 90.0
Wavelength (A˚) 1.075 0.979
Resolution (A˚)a 40.0–2.25 (2.29–2.25) 40.0–2.62 (2.67–2.62)
Rmerge (%)a 4.3 (30.3) 4.1 (29.4)
I/s(I)a 28.8 (2.2) 38.2 (4.6)
Completeness (%)a 97.6 (92.6) 100 (99.0)
Redundancya 2.7 (2.5) 3.9 (3.8)
Refinement
Resolution (A˚) 47.4–2.25
No. reflections 41,069
Rwork/Rfree (%) 20.6/25.4
No. atoms
(nonhydrogen)
6,884
Protein 6,436
RNA 298
Water 136
Phenol 14
B-factors (A˚2)
Protein 57.3
RNA 78.0
Water 46.8
Phenol 50.2
Rmsds
Bond lengths (A˚) 0.003
Bond angles () 0.674
MolProbity statistics
All atom clashscore 4.82
Poor rotamers (%) 0.98
Ramachandran
outliers (%)
0.0
Ramachandran
favored (%)
98.1
MolProbity score 1.42
The space group for both native and SeMet protein is P21.
aNumbers in parenthesis refer to the highest resolution shell.
Figure 2. Structure of hAgo2 in Complex with miR-20a
A schematic representation of the hAgo2-miR-20a complex is displayed with
each domain and interdomain linker labeled. The N domain is shown in blue,
the PAZ domain in red, theMid domain in green and the PIWI domain in purple.
The miRNA is shown in stick representation. The 50 end of miR-20a is bound to
the Mid domain. Nucleotides 2 to 10 track along the RNA binding groove, and
nucleotides 17 to 20 are bound to the PAZ domain. The location of the active
site is circled. For reference, a bar diagram is given below, color-coded as
described, indicating the positions of boundaries between structural domains.
Other views of the complex are shown in Figure S2.bridge, but it is unlikely that this interaction influences the posi-
tion of the PAZ domain relative to the body of the protein in our
structure.
Similarity was particularly striking when we aligned prokary-
otic and eukaryotic Argonaute structures based upon their
PIWI domains. This was true despite the fact that some of these
structures were determined in the presence of the guide and/or
target strands, whereas others reflected nonloaded proteins. All
showed a remarkably similar position and orientation of the N
and Mid domains. Thus, our findings and those of Schirle and
Macrae (2012) reveal that the overall structure and organization
of Argonaute proteins from evolutionarily distant organisms
and from all three kingdoms of life has been superblymaintained.Relative to their prokaryotic counterparts, eukaryotic Argo-
nautes contain a C-terminal insertion, whose structure was
revealed by crystallization of a fragment comprising the Mid
and PIWI domains of Neurospora QDE2 (Boland et al., 2011).
The insertion forms a pair of antiparallel helices that extend
from the PIWI domain and lead into the C terminus that nestles
between the Mid and PIWI domains. This insertion is only
partially visible in our structure of the hAgo2-miR-20a complex.
In a superposition of hAgo2 and QDE2, the insertion appears
to partially cover the small RNA binding groove of hAgo2;
however, the base edgeswould still be available for base pairing.
Thus, these remain available for pairing to the target strand (Fig-
ure S4). The insertion also appears to come fairly close to the
PAZ domain, leaving open the possibility that the two could
potentially interact. Given that the insertion is not resolved in
our structure, it might be sufficiently flexible to shift away from
the RNA binding groove, perhaps upon loading or target recog-
nition. Overall, the QDE-2 Mid-PIWI lobe aligns closely with the
same portion of the hAgo2-miR-20a complex, though the
hAgo2 Mid domain appears to be tilted a bit closer toward its
PIWI domain.Cell 150, 100–110, July 6, 2012 ª2012 Elsevier Inc. 103
Figure 3. Structural Comparison of hAgo2, PfAgo, and Tt Ago
Argonaute proteins across the three kingdoms of life show striking similarities
in their overall structures. All structures were superimposed based on their
respective PIWI domains and are oriented as in Figure 2. (A) hAgo2-miR-20a
complex adopts the most open conformation of all full-length Argonaute
structures determined to date. This is compared to the archaeal PfAgo (B),
eubacterial TtAgo bound to a 21-mer DNA guide (C), and TtAgo in complex
with a 21-mer DNA guide and a 19-mer RNA target (D). See also Figure S4.Our biochemical studies demonstrated that small RNA binding
conferred striking stability to hAgo2. Limited proteolysis of
the nonloaded protein by thermolysin produced two stable
fragments, with cuts at I427 and I577. In the hAgo2-miR-20a
complex, these residues are close neighbors, lying just about
10 A˚ apart. Spatially, they are located between the Mid and
PIWI domains, even though one sits in the primary sequence
on the linker between the PAZ and Mid domains (red spheres;
Figure 4). The overall structure suggests an explanation for
small RNA-induced resistance to proteolysis, namely that RNA
binding essentially ‘‘glues’’ the two domains together from the
opposite side. Given the proximity of these residues, thermolysin
would likely require some flexibility in the protein to access
these loops and cleave. This would seem possible only when
the bound small RNA is absent. In fact, the miRNA interacts
with all four domains of hAgo2 as well as with the linkers, likely
providing cohesion and rigidity to the whole structure.
In the complex, we can clearly resolve the positions of 14
nucleotides of miR-20a. These include the first 10 bases and
the final 4 (Figure S5). The electron density reflecting the central
six bases is less clear but is sufficient to serve as a guide for
model building (see below). The miRNA is anchored at both104 Cell 150, 100–110, July 6, 2012 ª2012 Elsevier Inc.ends to the protein, binding to the Mid and PAZ domains as
expected (Figure 5A).
The 50-End Binding Pocket of hAgo2
The 50 end of miR-20a is tethered to Argonaute through a multi-
tude of interactions to form a very tight binding pocket
composed of residues mostly from the Mid domain, as previ-
ously observed (Boland et al., 2011; Boland et al., 2010; Frank
et al., 2010; Ma et al., 2005; Parker et al., 2005). In the full-length
structure, it is clear that this pocket is also capped on one side
by PIWI domain residues (Figure 5B). All three nonbridging
oxygen atoms of the 50 phosphate interact with several residues.
The first interacts with the hydroxyl of Y529 and the amine of
K533 from the Mid domain and the R812 side chain from the
PIWI domain. This oxygen also forms a water-mediated interac-
tion with the C-terminal carboxylate of the protein. The second
oxygen interacts with the K570, K566, and Q545 side chains.
The main-chain amide of C546 and the side chain of K570
bind the third oxygen. Many of these residues are firmly posi-
tioned by interactions with each other and with additional
residues. In particular, T544 stabilizes K533, the C-terminal
carboxylate of the protein stabilizes K566 and K570, and the
water, which mediates interaction between the C terminus and
the 50 phosphate of the RNA, is stabilized by the main-chain
carbonyl of Y857 and the side chain of K533, among others.
We posit that the strong and extensive interactions between
the miRNA 50 phosphate and hAgo2 exquisitely define the
position of the RNA guide with respect to the active site to
ensure that cleavage of targets occurs at a well-defined and
predictable position. The other interactions that occur between
hAgo2 and the 50 end of the guide are neither as strong nor as
specific as for the 50-terminal phosphate. Thus, in the absence
of a 50 phosphate, the RNA guide might adopt a variety of
positions with the RNA binding groove of hAgo2, resulting in
a loss of fidelity in the definition of the target cleavage site. In
fact, this is precisely what was observed when hAgo2, purified
from bacteria, was programmed with guides that lacked a
terminal monophosphate (Rivas et al., 2005).
The 50 uridine in the hAgo2-miR-20a complex occupies a
position in the Mid domain that is essentially identical to that of
the UMP in the reported structure of the isolated hAgo2 Mid
domain (Frank et al., 2010). All previously identified residues
that interact with the base are in identical positions (Figure 5B).
The 20OH of the first sugar interacts with the Q548 side chain,
and the base itself stacks upon the aromatic ring of Y529. The
Watson-Crick base edge interacts with the peptide backbone
of G524-T525. Overall the structure of the isolated Mid domain
superimposes almost perfectly on the Mid domain analyzed in
the context of the full-length protein, with an RMSD of 0.69 A˚
between a-carbons.
Placement of the 50 nucleotide into its binding pocket
appears to be favored by additional structural constraints.
The second miRNA base (A2) abuts T563. L553 wedges itself
near the sugar, and N551 bounds the phosphate, practically di-
recting nucleotide 1 to insert into its binding site (Figure S6).
Occupancy of its binding pocket causes the first miRNA base
(U1) to be flipped away from the following nucleotides, making
it unavailable for interaction with the target. This is consistent
Figure 4. Structural Basis of RNA-Induced Stability of hAgo2
(A) hAgo2 is shown in the canonical view as in Figure 2 to highlight interactions of the RNA across all constituent domains of the protein. The two thermolysin
cleavage sites at I427 and I577 are shown as red spheres, which are only 10 A˚ apart and likely require flexibility in the protein for access by the protease. Extensive
interactions between the protein and RNA are proposed to ‘‘glue’’ the structure into place, preventing the needed flexibility.
(B) An additional view from the MID domain is shown, clarifying the location of the cleavage sites and the path of the RNA.with a wealth of prior structural, biochemical, and genetic data
(Bartel, 2009).
The miR-20a Seed Sequence and Kinky Turns
The seed sequence of miR-20a (A2-C8) sits in a rather narrow
groove. Every backbone phosphate of the seed and the adjacent
two nucleotides interacts with the protein (Figure 5A). The back-
bone phosphate of A2 interacts both with the main and side
chains of N551 and Q548. A3 interacts with K566 and R792,
A4 with R792, and G5 with Y804 and with both the main chain
and side chain of S798. U6 phosphate binds K709, G7 binds
R761, and C8 sees the main-chain amine of A221. The RNA is
held also by interactions with the sugars, particularly with
RNA-specific 20 OH groups of G5, G7, C8, and U10. The base
edges all face directly outward, leaving them available for pairing
with a target sequence. Because seed sequences are highly vari-
able, it is not surprising that we see only limited interactions
between hAgo2 and seed bases. The N3 of base A2 interacts
with the protein, but this atom does not contribute to Watson-
Crick base pairing. N2 and N3 on the minor groove side of the
G5 base are nicely coordinated by a bidentate interaction with
the side chain of Q757.
From the second (A2) to the sixth (U6) nucleotides, the bases
are continuously stacked, but there is a noticeable destacking of
bases 6 and 7 of the miRNA. This is a result of the insertion or
intercalation of the side chain of I365 between these two bases
(Figure 6C). This isoleucine emanates from the linker that
connects the PAZ domain with theMid domain and lies on a helix
on the back of the RNA binding groove. In the TtAgo-21-mer
complex, destacking also occurs, in this case between nucleo-tides 7 and 8 as a result of insertion of L267. Neither is this
change in conformation as pronounced nor is the side chain
intercalated as deeply as is seen in themiR-20a-hAgo2 complex.
Another major kink and change in the direction of the miRNA
occurs beyond the seed sequence between nucleotides U9
and U10 (Figure 5C). Here, two arginines play an important
role. R710 inserts itself into miR-20a, stacking on the U9 base
and interacting with the U10 phosphate. R635 stacks upon the
U10 base. Importantly, residues preceding one of these argi-
nines were shown to be important for hAgo2 function. Mutations
in Q633R, H634P, and H634A did not impact siRNA binding
but negated target cleavage (Liu et al., 2004). A third arginine,
R351, interacts with the backbone of U9. I353 also facilitates
the formation of the kink through van der Waals interactions.
The miRNA 30 End
The 30 end of miR-20a is tucked into the PAZ domain in a fashion
similar to that previously seen for the complex of the hAgo1 PAZ
domain with RNA (Ma et al., 2004). The last two nucleotides sit in
a cleft of the PAZ domain, being held by the bill of our proverbial
duck. The last base (A20) is stacked against F294, and the back-
bone phosphate that joins the last nucleotides makes a variety of
contacts, as previously observed. One nonbridging oxygen is
coordinated by two histidine side chains, those of H271 and
H316. A tyrosine, Y311, interacts both with the other nonbridging
oxygen through a hydroxyl group and with the bridging oxygen.
Of the final four bases, only the middle two, A18 and G19, are
stacked. G19 is destacked from the terminal base and C17
does not stack on G18 because the RNA turns sharply toward
the RNA binding groove of the protein at that point.Cell 150, 100–110, July 6, 2012 ª2012 Elsevier Inc. 105
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Figure 5. miR-20a Interactions with hAgo2
(A) A guide to the interactions between miR-20a (the first ten and last four bases that appear unambiguously in the structure) and hAgo2 is shown schematically.
Interactions with backbone phosphates, sugars, and bases are indicated according to the key. Interacting residues are color-coded with respect to their domain
location as in Figure 3.
(B) The site in the Mid domain (light green), which binds the 50 end of miR-20a is shown. The first miR-20a base (U1) and the terminal monophosphate are
displayed alongwith the interactions theymake with hAgo2. Interacting protein side chains are shown in stick representation in atom colors with carbons in white,
nitrogens in blue and oxygens in red. The 50U is shown in atom colors as above, but with carbons in blue and phosphorous in orange. The direction of the RNA
chain is shown as a dashed line. The portion of the PIWI domain, which caps the pocket, is shown in purple.
(C) The U6-G7 kink and the U9-U10 kink are shown in cartoon form. The L2 Linker is displayed in yellow, the PIWI domain in purple, and the miRNA in stick
as in (B).
See text for details. See also Figures S5 and S6.Modeling the Missing Links—Implications
for Target-Dependent RNA Movements
that Enable Substrate Cleavage
Although we could only unambiguously determine the structure
of 14 nucleotides, we saw clear electron density that almost
certainly corresponds to the backbone of miR-20a nucleotides
A11, A13, G14, and U15. We used this density as a guide for
theoretical modeling of the remainder of the miRNA (Figures
6A and 6C). A11 appears to stack on top of R179 and H-bond
with the side chain of S180. Interestingly, the backbone around
A13 and G14 makes a turn around an N-domain residue, P67.
This protrudes into the RNA binding groove like a knuckle at
a relatively restricted part of the RNA binding groove that is
bounded by the N domain on one side and the PAZ domain on
the other. This proline knuckle might play a role in N-domain-
assisted wedging of a loaded duplex strand as recently sug-
gested (Kwak and Tomari, 2012). There are several PAZ domain106 Cell 150, 100–110, July 6, 2012 ª2012 Elsevier Inc.residues in this area that likely provide interactions with the
miRNA, most notably K278 and R280 (Figure 6B).
The active site of hAgo2 is very similar in structure, positioning
and composition to Argonaute from P. furiosus (Rivas et al.,
2005; Song et al., 2004). It is composed of the two canonical
acidic residues, aspartates in this case (D597 and D669), projec-
ting from the slight opening in the central b sheet of the PIWI
domain. This arrangement is common to all enzymes of the
RNase H family. The active site is completed by a histidine,
H807, located on an adjacent a-helix. These are equivalent to
D558, D628, and H745 of the archaeal enzyme. hAgo2 is
a magnesium-dependent enzyme (Liu et al., 2004), and this
metal is very likely coordinated by active-site residues. We did
not identify any Mg2+ ions at the active site; however, Mg2+
was not included in the purification or crystallization buffers.
When examining the orientation of the miRNA with respect
to the active site, we expected nucleotides 10 and 11 to lie
Figure 6. Theoretical Modeling of the Complete miRNA
(A) Nucleotides 11–16 of miR-20a were modeled with guidance from residual
electron density (see text). Color coding is as in Figure 3. See also Figure S6.
(B) A close-up of the G14-U15 turn is displayed, showing the ‘‘proline knuckle’’
emanating from the N domain on one side and R278 and K280 emanating from
the PAZ domain on the other.
(C) The sequence of the 20-mer miR-20a is given. Ordered nucleotides are in
blue, modeled ones in pale blue. The amino acids in the proline knuckle
constriction are shown on both sides of the miRNA in green.opposite the active site. Instead, the active site sits opposite
nucleotides 9 and 10. We therefore expect the domain move-
ments associated with target binding to be a bit more complex
than simple opening of the binding groove and for these to
place the scissile phosphate in position to be cleaved by the
active site.
DISCUSSION
It is estimated that eukaryotic Argonautes have been diverging
from their archaeal counterparts for more than three billion years.
Yet, structural analyses in this work and by others of full-length
hAgo2 reveals remarkable similarity to both its archaeal and
eubacterial counterparts (Schirle and Macrae, 2012). The active
site is nearly identical between these enzymes, and the position
and orientation of the remaining structural domains with respectto the catalytic center is highly conserved. This defines a shared
positioning of the two ends of the nucleic acid guides used by
these enzymes to identify their targets. Though we still do not
know the biological functions of prokaryotic Argonautes, nor
the true nature of their guides and targets in vivo—whether
DNA or RNA—the deep conservation of Argonaute structure
implies that all kingdoms of life most likely use this enzyme in
basically the same way. This conclusion is particularly striking
when one considers the diversity of known biological roles for
Argonaute proteins, which seem to impact nearly every type of
biological process, and the diversity of mechanisms through
which Argonautes act. Not all Argonaute functions rely on their
shared catalytic mechanism, but some instead depend upon
the recruitment of accessory factors that enable, for example,
the control of protein synthesis or modification of chromatin
structure. Perhaps the evolutionary constraints implied by the
high degree of structural similarity among Argonautes are
simply defined by the overarching function of these proteins as
programmable instruments for target recognition by comple-
mentary base pairing, but they may also reflect additional
pressures.
The structure of hAgo2 in complex with miR-20a beautifully
illustrates how the guide is threaded through the entire protein
structure, interacting with every domain and even the linkers
that join them. Nearly all of the interactions between the guide
and the protein engage the RNA backbone, consistent with the
ability of Argonautes to accept small RNA cofactors of essen-
tially any sequence. The trajectory of the RNA is directed by
the protein through many kinks and turns but always in a fashion
that leaves most base edges accessible to be read by potential
target molecules. The logic underlying the path followed by the
RNA is not clear. As previously suggested, much of the seed is
positioned in a way to maximally favor target binding (Wang
et al., 2008b; Wang et al., 2009). Yet the circuitous route of the
remainder of the RNA likely also serves a function. It is possible
that this simply permits additional interactions between the
protein and RNA that optimize affinity for the guide. However,
the particular configuration of the RNA might also play as yet
unrealized roles.
Given that RNA binding confers remarkable stability upon
Argonaute proteins, the path of the guide might have evolved,
in part, to maximize mutual stability, making such complexes
long-lived. This is clearly critical in some settings. For example
in Drosophila, Piwi protein-piRNA complexes transmit epige-
netic information and likely must remain intact throughout a
substantial fraction of the fly life cycle (Brennecke et al.,
2008). The extensive interactions between hAgo2 and
miR-20a likely restrict domain movement, as implied by the
observed protease resistance of linker residues, but they might
also serve to functionally couple Argonaute protein domains.
Depending upon the degree of base pairing to the target, the
guide RNA might induce different movements of domains rela-
tive to each other. This would permit allosteric changes in the
complex that are sensitive to the mode of target interaction
and that might favor one set of protein-protein interactions or
one effector mode over another.
Asmentioned, the structure of hAgo2 in complexwith a hetero-
geneous mixture of bound RNAs of different lengths wasCell 150, 100–110, July 6, 2012 ª2012 Elsevier Inc. 107
reported recently (Schirle and Macrae, 2012). The structures are
very similar with an RMSD of 0.336 A˚ over 785 a-carbon atoms.
The main difference between the two structures is that the one
presented here is of a complex with a homogeneous, loaded
20-mer miRNA, whereas the other contains a heterogeneous
RNA. The clearer view of the boundmRNA in our structure allows
us to resolve the four nucleotides at the 30 end of miRNA-20a
bound to and extending from the PAZ domain, as well as three
additional nucleotides closer to the active site area with U9
and U10 forming an interesting kink. However, the path the
RNA takes at nucleotides 1–7 is almost identical between
the two structures, deviating a bit at nucleotides 6 and 7. Though
we were able to build a few more protein residues, even the
loops of the two structures are close to identical, a nice
commendation of macromolecular crystallography. Schirle and
MacRae (2012) also present a structure of a complex of hAgo2
with two molecules of tryptophan, which appear to bind to sites
in the PIWI domain that may represent GW182 binding sites
and thus a potential connection to the biochemical pathways
unique to eukaryotes.
We have yet to understand the structural nuances that define
different clades of Argonaute proteins, though emerging full-
length structures can begin to provoke theories of how alter-
ations in binding pockets might permit the binding of different
terminal structures by Wago clade proteins or underlie prefer-
ence for different terminal bases by Arabidopsis Argonautes.
The more variable positioning of the PAZ domain with respect
to the remainder of the protein might enable Piwi clade proteins
to selectively harbor longer RNA guides than members of the
Ago clade typically do.
Having the high-resolution 3D structure of the human version
of the most versatile of Argonautes in complex with a miRNA
provides an important framework to further understand its role
andmechanism of action in essential processes in human devel-
opment and disease.
EXPERIMENTAL PROCEDURES
Preparation of Small RNA Libraries
RNAwas prepared by using TRIZOL (Invitrogen) from SF9 cell pellets and from
a crystallization-grade hAgo2 preparation that retained endogenous small
RNAs; 19–29 nt long RNAs were PAGE purified from total SF9 RNA. Small
RNAs associated with hAgo2 were labeled with 32P-gamma ATP and sepa-
rated by Urea-PAGE. A size range of 19 to 25 nucleotides was selected, and
small RNAs were eluted from the gel. Small RNAs from SF9 cells and hAgo2
were both cloned according to (Brennecke et al., 2007), and sequenced on
an Illumina GA2 platform.
Bioinformatics Analysis of Small RNA Libraries
Illumina reads were stripped of the 30 linker and collapsed to a single represen-
tative of each sequence with multiplicity information retained. Reads that
matched to synthetic cloning markers as well as low complexity reads were
discarded. Only reads between 19 and 29 nt in length and that had amultiplicity
of at least ten in each sample were subjected to further analyses. For sequence
comparison between small RNAs associated with hAgo2 and endogenous
small RNAs from SF9 cells, sequences were compared by BLAT with tile
Size 11, minimum score 19 nt, and minimum identity of 90%.
Protein Expression and Purification
The full-length wild-type hAgo2 gene was cloned into the pFL vector of the
MultiBac baculovirus expression system (Bieniossek et al., 2008) with108 Cell 150, 100–110, July 6, 2012 ª2012 Elsevier Inc.a Two-Strep-SumoStar (TSS) tag (based on the One-Strep-SumoStar [OSS]
tag [Schalch et al., 2011]) followed by a TEV cleavage site. SF9 insect cells,
grown in Hyclone CCM3 media (Thermo Scientific), were infected with a
baculovirus expressing hAgo2 for 72 hr. Initial purification was done by using
Strep-Tactin superflow resin (IBA bioTAGnology) followed by tag removal with
TEV protease. Protein was then loaded onto a Mono S 5/50 column (GE
Healthcare) equilibrated with 20 mM Tris pH = 8.0, 50 mM KCl, and 5 mM
DTT. Elution with the same buffer at 150 mM KCl and 375 mM KCl concentra-
tions resulted in two separated fractions of protein, one that was bound to
endogenous RNA originating from the insect cells and a second that was
RNA free as determined by the ratio of 260/280 nm UV absorption and RNA
extractions from the two samples.
Limited Proteolysis
The protocol used was adapted from Phan and colleagues (Phan et al., 2004);
1 mg/ml thermolysin (EMD Biosciences) stock solution was prepared in
thermolysin reaction buffer (10 mM Tris-HCl [pH 8.0], 2 mM CaCl2, and 5%
glycerol). Ten micrograms of hAgo2 were incubated with a 1:10, 1:40, 1:640,
and 1:2,560 serial dilutions of the thermolysin protease for 30 min at 37C.
The reactions were quenched by the addition of SDS loading dye supple-
mented with 25 mM EDTA and boiling for 5 min. Samples were analyzed by
SDS-PAGE, N-terminal sequencing, and mass spectrometry.
Complex Preparation
Human miR-20a-derived 20-mer of the sequence 50 p-UAAAGUGCUUAUA
GUGCAGG-30 (Dharmacon RNAi technologies) was added to the RNA-free
protein fraction at a 1:2 (protein:miRNA) molar ratio. Excess miR-20a was
separated from the hAgo2-miR-20a complex by size exclusion chromatog-
raphy that used a Superdex 200 10/300 column equilibrated with 10 mM
Tris pH = 8.0, 100 mM NaCl, and 5 mM DTT.
Selenomethionine Protein Expression and Purification
High-five cells were infected with a baculovirus that directs expression of
full-length, wild-type hAgo2 in ESF921 media (Expression Systems) for 6 hr,
followed by media exchange to a methionine-free media and further growth
for an additional 4 hr. Selenomethionine (SeMet) was then added to a final
concentration of 198 mg/L. The cells were harvested after 48 hr. Incorporation
was assessed by using mass spectrometry. SeMet protein purification and
crystallization were done in the same manner as with the native protein.
Protein Crystallization and Data Collection
Crystals were initially obtained by hanging-drop vapor diffusion after mixing
the protein-RNA complex at 5 mg/ml with an equal volume of 100 mM Tris
[pH = 9.0], 14% PEG 3350 (w/v), 11% 2-propanol (v/v), and 0.12 M phenol.
The inclusion of phenol was based on the early identification by the MacRae
lab of phenol as a critical component of the crystallization conditions, as
subsequently reported in Schirle and MacRae (2012). Further optimization of
crystal growth was done by microseeding by mixing 1 ml of 100 mM Tris
[pH = 9.0], 10%–12% PEG 3350 (w/v), 8%–10% 2-propanol (v/v), and
0.12 M phenol (v/v) with 1–3 ml of the protein. For data collection, crystals
were cryoprotected by transferring the crystals briefly into the reservoir
solution supplemented with 25% (v/v) ethylene glycol and flash freezing in
liquid nitrogen.
X-ray diffraction data of native and SeMet-derivatized hAgo2 were
collected to 2.2 A˚ and 2.6 A˚ resolution at beamline X29 at the National
Synchrotron Light Source (NSLS) at Brookhaven National Laboratory
(BNL). Diffraction data were indexed, integrated, and scaled with HKL2000
(Otwinowski and Minor, 1997). The structure of the SeMet crystal was deter-
mined by SAD at a wavelength optimized for the f00 signal of selenium. Eigh-
teen selenium sites were found by using the HKL2MAP (Pape and Schneider,
2004) interface of SHELXD (Sheldrick, 2008). Heavy atom phasing was per-
formed with SHARP (Bricogne, 1997). Density modification and phase exten-
sion to 2.2 A˚, starting from the initial SHARP phases, was performed with the
native data by solvent flattening as implemented in SOLOMON (Abrahams
and Leslie, 1996). Automated model building with PHENIX (Adams et al.,
2010) resulted in a partial model that was completed with manual correction
with COOT (Emsley et al., 2010). After initial cycles of refinement with
PHENIX and Refmac (Murshudov et al., 1997) automatically detected TLS
groups were included as implemented in PHENIX (Version 1.7.2.869).
Geometrical restraints were tightly monitored, and the inclusion of riding
hydrogens resulted in significantly improved geometry of the refined model.
The final structure could be refined to an Rwork/Rfree of 20.6%/25.4%.
The final model is missing residues 1–22, 120–126, 186–188, 245–247, 273–
275, 603–606, 821–836 (58 of 859 residues). It contains two phenols retained
from the crystallization condition and comprises nucleotides 1–10 and 17–20
ofmiR-20a. Nucleotides 11–16were not included in refinement; however, frag-
mented density for nucleotides 13–15 allowed the modeling of the complete
miRNA.
Figures were generated by using PyMol (The PyMOL Molecular Graphics
System, Version 1.3 Schro¨dinger.).
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After this paper was accepted, a related paper was published online by
Nakanishi et al., reporting the crystal structure of the yeast Kluyveromyces
polysporus Argonaute loaded with guide RNA. Nakanishi, K., Weinberg,
D.E., Bartel, D.P., and Patel, D.J. (2012). Structure of yeast Argonaute with
guide RNA. Nature. Published online May 18, 2012. 10.1038/nature11211.
